sulfaphenazole has been researched along with Heart Failure in 2 studies
Sulfaphenazole: A sulfonilamide anti-infective agent.
sulfaphenazole : A sulfonamide that is sulfanilamide in which the sulfonamide nitrogen is substituted by a 1-phenyl-1H-pyrazol-5-yl group. It is a selective inhibitor of cytochrome P450 (CYP) 2C9 isozyme, and antibacterial agent.
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Heim, R | 1 |
Lucas, S | 1 |
Grombein, CM | 1 |
Ries, C | 1 |
Schewe, KE | 1 |
Negri, M | 1 |
Müller-Vieira, U | 1 |
Birk, B | 1 |
Hartmann, RW | 1 |
Fischer, D | 1 |
Landmesser, U | 1 |
Spiekermann, S | 1 |
Hilfiker-Kleiner, D | 1 |
Hospely, M | 1 |
Müller, M | 1 |
Busse, R | 1 |
Fleming, I | 1 |
Drexler, H | 1 |
2 other studies available for sulfaphenazole and Heart Failure
Article | Year |
---|---|
Overcoming undesirable CYP1A2 inhibition of pyridylnaphthalene-type aldosterone synthase inhibitors: influence of heteroaryl derivatization on potency and selectivity.
Topics: Animals; Cytochrome P-450 CYP11B2; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Fibr | 2008 |
Cytochrome P450 2C9 is involved in flow-dependent vasodilation of peripheral conduit arteries in healthy subjects and in patients with chronic heart failure.
Topics: Aged; Anti-Infective Agents; Arteries; Aryl Hydrocarbon Hydroxylases; Chronic Disease; Cytochrome P- | 2007 |